Large pharmaceutical conglomerate Eli Lilly has announced plans to build a $6 billion manufacturing facility in Huntsville, Alabama. The site will focus on the production of small molecules and ...

Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...

The legislature hopes to establish a domestic center of excellence for biopharmaceutical manufacturing.

We spoke with representatives from Anthony Nolan and eXmoor to discuss both their collaboration and the importance of ethical ...

AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

Explore the latest news and expert commentary by Quentin Leclerc, brought to you by the Contributor of BioProcess International.